Geoffrey M. Parker, Director at Better Therapeutics, Inc. (BTTX), bought 40,000 shares at $4.94 ($198K) on 2021-12-14, disclosed to the SEC on 2021-12-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.94 | 20,000 | $99K | 50.0% |
| 2 | $4.94 | 20,000 | $99K | 50.0% |
| Total | $4.94 avg | 40,000 | $198K | 100% |
| Filing → |
| ALLO | SELL | 2025-10-23 | $46K | — | Filing → |
| PRGO | BUY | 2025-08-20 | $201K | — | Filing → |
| PRGO | BUY | 2025-05-14 | $95K | — | Filing → |